ANI Pharmaceuticals, Inc.
NASDAQ:ANIP
53.35 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 486.816 | 316.385 | 216.136 | 208.475 | 206.547 | 201.576 | 176.842 | 128.622 | 76.322 | 55.97 | 30.082 | 2.301 | 0.435 | 2.474 | 1.258 | 3.781 | 0.493 | 14.439 | 0.258 | 0.078 | 0.065 | 2.834 | 1.747 | 0 | 0 | 0.123 |
| Cost of Revenue
| 181.513 | 138.785 | 100.61 | 87.157 | 63.154 | 73.024 | 79.032 | 48.78 | 12.692 | 11.473 | 9.974 | 9.167 | 0.05 | 0.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.024 | 0 | 0 |
| Gross Profit
| 305.303 | 177.6 | 115.526 | 121.318 | 143.393 | 128.552 | 97.81 | 79.842 | 63.63 | 44.497 | 20.108 | -6.866 | 0.385 | 2.205 | 1.258 | 3.781 | 0.493 | 14.439 | 0.258 | 0.078 | 0.065 | 2.834 | 1.747 | 0.024 | 0 | 0.123 |
| Gross Profit Ratio
| 0.627 | 0.561 | 0.535 | 0.582 | 0.694 | 0.638 | 0.553 | 0.621 | 0.834 | 0.795 | 0.668 | -2.984 | 0.885 | 0.891 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 12,146 | 1 | 1 |
| Reseach & Development Expenses
| 34.286 | 22.318 | 11.369 | 16.001 | 19.806 | 15.388 | 9.07 | 2.906 | 2.874 | 2.678 | 1.712 | 16.889 | 44.182 | 39.706 | 13.681 | 15.79 | 4.751 | 3.856 | 6.409 | 9.162 | 3.691 | 4.787 | 2.142 | 1.888 | 0.661 | 1.4 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 44.063 | 31.58 | 27.829 | 21.156 | 17.935 | 16.388 | 8.23 | 6.981 | 5.94 | 5.674 | 5.961 | 4.331 | 7.025 | 3.051 | 3.08 | 2.327 | 1.766 | 2.299 | 1.679 | 0.853 | 1.113 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 161.697 | 124.044 | 84.294 | 64.986 | 55.843 | 44.063 | 31.58 | 27.829 | 21.156 | 17.935 | 16.388 | 8.23 | 6.981 | 5.94 | 5.674 | 5.961 | 4.331 | 7.025 | 3.051 | 3.08 | 2.327 | 1.766 | 2.299 | 1.679 | 0.853 | 1.113 |
| Other Expenses
| 62.349 | 56.972 | 48.032 | 55.901 | 51.318 | -0.55 | 0.055 | -0.074 | 0.041 | 0.16 | -0.305 | 0.354 | 0.148 | 0.168 | 20.329 | 0.043 | 0.09 | 0.118 | 0.101 | 0.102 | 0.093 | 0.092 | 0.093 | 0.123 | 0.091 | 0.27 |
| Operating Expenses
| 258.332 | 203.334 | 143.695 | 136.888 | 126.967 | 93.193 | 68.578 | 53.078 | 30.93 | 24.491 | 19.21 | 25.472 | 51.312 | 45.814 | 39.684 | 21.794 | 9.172 | 10.999 | 9.561 | 12.345 | 6.111 | 6.645 | 4.533 | 3.689 | 1.605 | 2.782 |
| Operating Income
| 46.971 | -25.064 | -32.512 | -16.064 | 16.351 | 35.359 | 28.329 | 20.079 | 32.7 | 20.006 | 0.898 | -23.172 | -50.927 | -43.608 | -38.426 | -18.014 | -8.679 | 3.44 | -9.302 | -12.267 | -6.046 | -3.811 | -2.786 | -3.665 | -1.605 | -2.659 |
| Operating Income Ratio
| 0.096 | -0.079 | -0.15 | -0.077 | 0.079 | 0.175 | 0.16 | 0.156 | 0.428 | 0.357 | 0.03 | -10.071 | -117.03 | -17.625 | -30.544 | -4.764 | -17.603 | 0.238 | -36.006 | -157.495 | -92.313 | -1.345 | -1.594 | -1,832,455.5 | -1,604,941 | -21.611 |
| Total Other Income Expenses Net
| -27.099 | -27.382 | -16.265 | -9.946 | -13.194 | -15.308 | -11.98 | -11.401 | -10.967 | -0.627 | -0.772 | -5.597 | -0.682 | -2.588 | -9.102 | -17,407.164 | -7,575.756 | -1.077 | -0.349 | 0.25 | 0.087 | 0 | 0.174 | 0 | 0 | 0 |
| Income Before Tax
| 19.872 | -62.665 | -56.058 | -25.962 | 3.157 | 20.051 | 16.349 | 8.678 | 21.733 | 19.379 | 0.126 | -27.84 | -51,608.504 | -46,196.216 | -47,527.768 | -17,425.178 | -7,584.435 | 2,791.273 | -9,651.036 | -12.016 | -5.959 | -3.811 | -2.611 | 0 | 0 | 0 |
| Income Before Tax Ratio
| 0.041 | -0.198 | -0.259 | -0.125 | 0.015 | 0.099 | 0.092 | 0.067 | 0.285 | 0.346 | 0.004 | -12.1 | -118,596.617 | -18,670.894 | -37,778.798 | -4,608.825 | -15,382.565 | 193.32 | -37,356.294 | -154.279 | -90.991 | -1.345 | -1.494 | 0 | 0 | 0 |
| Income Tax Expense
| 1.093 | -14.769 | -13.455 | -3.414 | -2.937 | 4.557 | 17.425 | 4.744 | 6.358 | -9.368 | 0.02 | -0.122 | 0.682 | 2.588 | 9.102 | -17,407.753 | -7,576.851 | 0.648 | 0.349 | 0 | 0 | 0 | 0 | -0.228 | -0.199 | 0 |
| Net Income
| 18.779 | -47.896 | -42.603 | -22.548 | 6.094 | 15.494 | -1.076 | 3.934 | 15.375 | 28.747 | 0.301 | -27.718 | -51.609 | -46.196 | -47.528 | -17.425 | -7.584 | 2.791 | -9.651 | -12.016 | -5.959 | -3.811 | -2.611 | -3.437 | -1.406 | -2.659 |
| Net Income Ratio
| 0.039 | -0.151 | -0.197 | -0.108 | 0.03 | 0.077 | -0.006 | 0.031 | 0.201 | 0.514 | 0.01 | -12.047 | -118.597 | -18.671 | -37.779 | -4.609 | -15.383 | 0.193 | -37.356 | -154.279 | -90.991 | -1.345 | -1.494 | -1,718,597.5 | -1,406,259 | -21.611 |
| EPS
| 0.95 | -2.95 | -3.38 | -1.88 | 0.51 | 1.33 | -0.093 | 0.34 | 1.34 | 2.61 | -0.92 | -7.64 | -18.88 | -25.23 | -50.39 | -22.97 | -10.71 | 4.68 | -17.92 | -25.23 | -19.44 | -18.28 | -14.5 | -21.51 | -10.24 | -27.47 |
| EPS Diluted
| 0.94 | -2.95 | -3.38 | -1.88 | 0.5 | 1.32 | -0.093 | 0.34 | 1.32 | 2.59 | -0.92 | -7.64 | -18.88 | -25.23 | -50.39 | -22.97 | -10.71 | 4.68 | -17.92 | -25.23 | -19.44 | -18.28 | -14.5 | -21.51 | -10.24 | -27.47 |
| EBITDA
| 106.599 | 48.068 | -1.684 | 29.068 | 60.735 | 69.101 | 57.16 | 56.307 | 39.641 | 24.044 | 7.508 | -27.233 | -50.779 | -45.34 | -47.243 | -17.382 | -7.495 | 3.558 | -9.55 | -11.914 | -5.953 | -3.719 | -2.675 | -3.314 | -1.514 | -2.52 |
| EBITDA Ratio
| 0.219 | 0.101 | 0.068 | 0.137 | 0.294 | 0.34 | 0.324 | 0.381 | 0.519 | 0.43 | 0.057 | -9.955 | -116.67 | -16.784 | -23.307 | -4.753 | -17.421 | 0.321 | -32.712 | -156.186 | -90.894 | -1.312 | -1.531 | -1,771,060.5 | -1,513,976 | -20.475 |